| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/17/2008 | CN100443593C Methods for stable transduction of cells with viral vectors |
| 12/17/2008 | CN100443503C Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin |
| 12/17/2008 | CN100443501C Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof |
| 12/17/2008 | CN100443495C Triterpene saponin compound of cycro jackfruit alkyl, and effect for anti tumor |
| 12/17/2008 | CN100443486C 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443476C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 12/17/2008 | CN100443472C 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 12/17/2008 | CN100443118C Dosages for treatment with anti-ErbB2 antibodies |
| 12/17/2008 | CN100443106C A medicine for treating malignant tumour |
| 12/17/2008 | CN100443080C Medicinal composition for preventing and treating cancer diseases |
| 12/16/2008 | US7465803 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 12/16/2008 | US7465753 hydrophobic drug having (a) glycoside like GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal-, Gal-Glc-, as sugar moiety (b) phosphatidylcholines (c) stearylamine or oleylamine; composition improves the low solubility of gylcoside; cholestenol glycoside anticancer drug; improved drug delivery |
| 12/16/2008 | US7465746 Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465734 Detecting potential therapeutic agent |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465719 e.g. 4-{[(Benzyloxy)amino]carbonyl}phenyl 1-(4-methoxyphenyl)cyclohexanecarboxylate; histone deacetylase inhibitor; anticarcinogenic, antiproliferative agent; neurodegenerative diseases; bactericide; psoriasis, osteoarthritis; rheumatoid arthritis, malaria, protozoal infection, Alzheimer's; Parkinson's |
| 12/16/2008 | US7465718 Ansamycins having improved pharmacological and biological properties |
| 12/16/2008 | US7465583 Comprising adeno-associated virus terminal repeat sequences; intrastrand base-pairing |
| 12/16/2008 | US7465553 Psoriasin expression by breast epithelial cells |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
| 12/16/2008 | US7465541 Vitamin D3-responsive sequences located 5′-upstream of p27/kip 1 gene and methods of screening for pharmaceutical agents using the sequences |
| 12/16/2008 | US7465452 Tumor antigen |
| 12/16/2008 | US7465449 Anti-αvβ6 antibodies |
| 12/16/2008 | CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 12/16/2008 | CA2298018C Methods and compositions for inhibiting angiogenesis |
| 12/16/2008 | CA2294913C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 12/16/2008 | CA2253632C Compositions and methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
| 12/16/2008 | CA2239692C Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 12/11/2008 | WO2008150957A2 Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles |
| 12/11/2008 | WO2008150899A1 Combination therapies for treatment of cancer and inflammatory diseases |
| 12/11/2008 | WO2008150799A1 Imidazopyridine kinase inhibitors |
| 12/11/2008 | WO2008150782A1 Use of hdac inhibitors for the treatment of bone destruction |
| 12/11/2008 | WO2008150532A1 Methods and compositions for treating recurrent cancer |
| 12/11/2008 | WO2008150260A1 8-oxy-2-aminopyrido (2, 3-d) pyrimidin-7-one derivatives as kinase inhibitors and anticancer agents |
| 12/11/2008 | WO2008150015A1 Heterobicyclic compounds as kinase inhibitors |
| 12/11/2008 | WO2008149782A1 Prognostic factor in sarcoma, and metastasis inhibitor |
| 12/11/2008 | WO2008149521A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/11/2008 | WO2008149311A1 Use of derivatives of 3-oxo-2,3-dihydro-5h-thiazolof[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5h-selenazolo[3,2-a]pyrimidine or of 3-oxo-1,2,3-trihydro-5h-imidazolo[1,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer |
| 12/11/2008 | WO2008148884A1 Compositions and methods for treating pancreatic tumors |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | WO2008148849A2 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148617A1 Beta-carboline arylsulfonamides, method for preparing them and composition comprising them |
| 12/11/2008 | WO2008148546A2 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 12/11/2008 | WO2008148449A1 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors |
| 12/11/2008 | WO2008148359A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 12/11/2008 | WO2008148269A1 Anti-tumor medicine containing betulinic acid derivatives |
| 12/11/2008 | WO2008148260A1 A novel crystal form of irinotecan hydrochloride and its preparation |
| 12/11/2008 | WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 12/11/2008 | WO2008128171A3 Diazo bicyclic smac mimetics and the uses thereof |
| 12/11/2008 | WO2008120101A3 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 12/11/2008 | WO2008118369A3 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity |
| 12/11/2008 | WO2008116665A8 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 12/11/2008 | WO2008113863A3 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 12/11/2008 | WO2008112199A8 Method for inhibiting topoisomerase ii |
| 12/11/2008 | WO2008111918A3 Combination containing plant extracts and use thereof for the treatment of various types of cancer |
| 12/11/2008 | WO2008110491A3 Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| 12/11/2008 | WO2008109560A3 Amelioration of cellular stress response |
| 12/11/2008 | WO2008109454A3 Nucleic acid compounds for inhibiting fos gene expression and uses thereof |
| 12/11/2008 | WO2008109368A3 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof |
| 12/11/2008 | WO2008106131A3 Combination therapy for treatment of immune disorders |
| 12/11/2008 | WO2008103693A3 Chemical linkers with single amino acids and conjugates thereof |
| 12/11/2008 | WO2008102075A3 Novel therapeutic use for treating leukaemia |
| 12/11/2008 | WO2008100621A3 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
| 12/11/2008 | WO2008100384A3 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 12/11/2008 | WO2008087458A3 NEW SIGMA(σ)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION |
| 12/11/2008 | WO2008087025A3 Specific therapy and medicament using integrin ligands for treating cancer |
| 12/11/2008 | WO2008063671A3 Heterobicyclic metalloprotease inhibitors |
| 12/11/2008 | WO2008045461A3 Transdermal diethylstilbestrol for treating prostate cancer |
| 12/11/2008 | WO2008044782A3 Combination drug |
| 12/11/2008 | WO2007116029A3 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 12/11/2008 | WO2007096618A3 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use |
| 12/11/2008 | US20080306148 Anti-cancer compositions and methods |
| 12/11/2008 | US20080306147 Illudin Analogs Useful as Anticancer Agents |
| 12/11/2008 | US20080306146 Dosing Regimens for Cox-2 Inhibitor |
| 12/11/2008 | US20080306140 Isoflavonoid Dimers |
| 12/11/2008 | US20080306137 Pharmaceutical compositions comprising docetaxel and methods for preparation thereof |
| 12/11/2008 | US20080306124 Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands |
| 12/11/2008 | US20080306118 Process for the crystallization of (R) - or (S) - Lansoprazole |
| 12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
| 12/11/2008 | US20080306100 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| 12/11/2008 | US20080306097 Cancer Treatment Method |
| 12/11/2008 | US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents |
| 12/11/2008 | US20080306094 Combination of Azd2171 and Pemetrexed |
| 12/11/2008 | US20080306082 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases |
| 12/11/2008 | US20080306073 Antitumor Effect Potentiator, Antitumor Preparation, and Method for Treating Cancer |
| 12/11/2008 | US20080306069 Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S |
| 12/11/2008 | US20080306065 Metalloproteinase Inhibitors |
| 12/11/2008 | US20080306063 Phenylamino isothiazole carboxamidines as mek inhibitors |
| 12/11/2008 | US20080306052 e.g.1-{3-[5-(4-chlorophenyl)-2-oxo-6H-1,3,4-thiadiazin-3-ylmethyl]phenyl}-3-(1-methylpyrrolidin-3-ylmethyl)urea; inhibitors of tyrosine kinases, in particular Met kinase; antitumor, antiinflammatory agent |
| 12/11/2008 | US20080306042 Triazole Derivatives |
| 12/11/2008 | US20080306028 Erianin Salts, Their Preparation Methods and Pharmaceutical Compositions Containing the Same |
| 12/11/2008 | US20080306027 Fluoroalkoxycombretastatin Derivatives, Method For Producing the Same and Use Thereof |
| 12/11/2008 | US20080306018 Micro-Rna Expression Abnormalities of Pancreatic, Endocrine and Acinar Tumors |
| 12/11/2008 | US20080306017 Microrna-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer |
| 12/11/2008 | US20080306013 Illudin analogs useful as antitumor agents |
| 12/11/2008 | US20080306011 Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation |